LONDON--(BUSINESS WIRE)-- #HEOR--Causaly, the AI company teaching computers to read, understand and interpret biomedical knowledge, is pleased to announce its series A fundraising round, which saw new and existing investors commit $4.8m into the company. Pentech Ventures led the round together with EBRD Venture Capital, with participation from existing investors Marathon Venture Capital. 100,000 biomedical articles are added each month to the over 30 million already published – which makes it time-cons.